Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,894,037 papers from all fields of science
Search
Sign In
Create Free Account
Cyclin G2
Known as:
Cyclin G2 [Chemical/Ingredient]
An unusual cyclin subtype that is found highly expressed in terminally differentiated cells. Unlike conventional cyclins increased expression of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
CCNG2 gene
In Blood
Process of secretion
agonists
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
S. Bernaudo
,
Mohamed Salem
,
+12 authors
Chun Peng
Oncogene
2016
Corpus ID: 52807508
Epithelial ovarian cancer (EOC) has the highest mortality rate among gynecological malignancies owing to poor screening methods…
Expand
2014
2014
MicroRNA-378a-5p Targets Cyclin G2 to Inhibit Fusion and Differentiation in BeWo Cells1
Uzma Nadeem
,
G. Ye
,
M. Salem
,
C. Peng
Biology of Reproduction
2014
Corpus ID: 9368509
ABSTRACT MicroRNAs are expressed abundantly in the placenta throughout pregnancy. We have previously reported that microRNA (miR…
Expand
2014
2014
Cyclin G2 Suppresses Estrogen-Mediated Osteogenesis through Inhibition of Wnt/β-Catenin Signaling
Jinlan Gao
,
Qi Liu
,
+4 authors
Yang Luo
PLoS ONE
2014
Corpus ID: 4594249
Estrogen plays an important role in the maintenance of bone formation, and deficiency in the production of estrogen is directly…
Expand
2014
2014
Changes in the expression of cyclin G2 in esophageal cancer cell and its significance
J. Chen
,
C. Liu
,
+4 authors
G. Sun
Tumor Biology
2014
Corpus ID: 18750341
This study aimed to analyze the expression, clinical significance of cyclin G2 (CCNG2) in esophageal carcinoma, and the…
Expand
2012
2012
The expression of cyclin G in nasopharyngeal carcinoma and its significance
Xing-Xing Ye
,
Chi-bo Liu
,
Jia-Yu Chen
,
Bao-hong Tao
,
Cai Zhi-yi
Clinical and Experimental Medicine (Testo…
2012
Corpus ID: 22456417
To investigate the expression of cyclin G1, cyclin G2 in nasopharyngeal carcinoma (NPC) cell lines and its significance. The…
Expand
2009
2009
Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
M. Choi
,
J. Noh
,
+6 authors
Sung Kim
Journal of Surgical Research
2009
Corpus ID: 20170442
Highly Cited
2008
Highly Cited
2008
Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7.
Guoxiong Xu
,
S. Bernaudo
,
G. Fu
,
Daniel Y. Lee
,
Burton B. Yang
,
C. Peng
Molecular Biology of the Cell
2008
Corpus ID: 25529842
We have previously reported that Nodal, a member of the TGF-beta superfamily, acts through activin receptor-like kinase 7 (ALK7…
Expand
Highly Cited
2004
Highly Cited
2004
Cyclin G2 Dysregulation in Human Oral Cancer
Yong Kim
,
S. Shintani
,
Y. Kohno
,
Rong-hua Zhang
,
D. Wong
Cancer Research
2004
Corpus ID: 18165485
Using expression microarray, we have previously shown that human cyclin G2 (hCG2) is significantly down-regulated in laser…
Expand
2003
2003
Decreased expression of cyclin G2 is significantly linked to the malignant transformation of papillary carcinoma of the thyroid.
Yasuhiro Ito
,
H. Yoshida
,
+8 authors
A. Miyauchi
Anticancer Research
2003
Corpus ID: 24045588
BACKGROUND Cyclin G2 is a novel cyclin negatively regulating the cell cycle progression, contrary to the characteristics of…
Expand
Highly Cited
1996
Highly Cited
1996
Characterisation of human cyclin G1 and G2: DNA damage inducible genes.
S. Bates
,
S. Rowan
,
K. Vousden
Oncogene
1996
Corpus ID: 34178865
Several genes have been identified as targets for transcriptional activation by the p53 tumour suppressor protein. Rodent cyclin…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE